Belong Works with the American Cancer Society to Bring Millions of Cancer Patients A Mobile Information Hub At Their Fingertips. The American Cancer Society partners with Belong: Beating Cancer Together, providing patients living with cancer and care providers access to high quality information and support New York — November 2017 — Belong Beating cancer together is adding an American … Continued
Barbara Jacoby is an award winning blogger that has contributed her two time Breast Cancer journey, patient advocacy mission and Domestic Abuse experience to multiple online publications that have touched readers worldwide. Link to the blog post: http://www.letlifehappen.com/belong-social-network-providing-cancer-support-patients-families/
Belong was selected by the Huffington Post as one of the revolutionary MedTech technologies. https://goo.gl/odZK2T
Announcing a New Neurosurgical Med group! Here at Belong, we listen to your requests and do everything we can to help you in your fight against cancer. We are building an ecosystem of knowledge and support that is relevant and personalized to your needs, to help you on your journey. The new group will be … Continued
Belong was just rated as one of the top 10 Health apps according to the Appliv ranking.
CancerToday – A leading Cancer magazine in the US, talks about Belong and its’ values for patients, survivors and Friends.
Eliran Malki, CEO of Belong, at the OECT (Operational Excellence in Clinical Trials) Summit in Berlin in front of Pharma & Providers executives from all over the globe talking about how Belong, patient engagement & patient navigation changes the way clinical trials are being conducted. From the conference agenda : Title: Clinical Trials and Patient … Continued
Listen to Eliran Malki, Belong’s CEO at the eHealthRadio : https://ehealthradio.podbean.com/e/how-to-navigate-cancer-using-mobile-technology-and-the-wisdom-of-the-crowd
Belong news: New Melanoma Med group managed by Prof. Michal Lotem has been launched! Prof. Lotem is the head of the Melanoma and Immunotherapy Unit at the Sharet Oncology Dep. at the HMC and an international expert in skin cancer, clinical oncology and radiotherapy. Prof. Lotem was involved in research, with Dr. Steven … Continued